Two studies reflect growing confidence in novel therapy for non-melanoma skin cancer
Non-melanoma skin cancer (NMSC) is the most common type of cancer. NMSC treatment can be…
Author OncoBeta
Australia: A Key Focus for Oncobeta
With one of the highest incidences of skin cancer in the world found here in…
Protected: A new treatment breakthrough for non-melanoma skin cancer
This content is password protected. To view it please enter your password below: Password:
Protected: 2022: A breakthrough year for OncoBeta’s Rhenium-SCT®
This content is password protected. To view it please enter your password below: Password:
Protected: OncoBeta’s CEO and Managing Director Shannon D. Brown III talks about its innovative non-invasive skin cancer treatment Rhenium-SCT®
This content is password protected. To view it please enter your password below: Password: